George Simeon
Related Filers (16)
- CRISPR Therapeutics AG (10)
- Turning Point Therapeutics, Inc. (7)
- Principia Biopharma Inc. (7)
- Nkarta, Inc. (6)
- Design Therapeutics, Inc. (6)
- SR ONE CAPITAL MANAGEMENT, LLC (5)
- SR One Capital Fund I Aggregator LP (5)
- SR ONE CAPITAL PARTNERS I, LP (5)
- SR One Co-Invest II, LLC (3)
- Arcellx, Inc. (3)
- GENOCEA BIOSCIENCES, INC. (2)
- eFFECTOR Therapeutics, Inc. (2)
- SR One Co-Invest II Manager, LLC (2)
- SR One Co-Invest I, LLC (2)
- SR One Co-Invest I Manager, LLC (2)
- HTG MOLECULAR DIAGNOSTICS, INC (1)
- Show More ...
Ownership (44)
4
Wednesday, 11/29/2023
eFFECTOR Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/9/2023
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Friday, 6/9/2023
Nkarta, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/2/2023
Design Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/15/2023
Arcellx, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/20/2022
Design Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/17/2022
Turning Point Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/16/2022
Design Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2022
Nkarta, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2022
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Friday, 4/29/2022
Nkarta, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/10/2022
Arcellx, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 2/3/2022
Arcellx, Inc.: Initial statement of beneficial ownership of securities
3
Thursday, 9/2/2021
eFFECTOR Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 6/15/2021
Nkarta, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/14/2021
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Friday, 6/4/2021
Turning Point Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/1/2021
Design Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/29/2021
Design Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 3/25/2021
Design Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 9/28/2020
Principia Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/13/2020
Nkarta, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/9/2020
Nkarta, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 6/17/2020
Turning Point Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/15/2020
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Monday, 6/8/2020
Principia Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/26/2020
Turning Point Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/22/2019
Principia Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/11/2019
Turning Point Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/13/2019
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/11/2019
Principia Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/24/2019
Turning Point Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 4/16/2019
Turning Point Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 1/10/2019
Principia Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/20/2018
Principia Biopharma Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 9/13/2018
Principia Biopharma Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 6/19/2018
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Friday, 6/2/2017
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/26/2016
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Thursday, 10/20/2016
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
3
Tuesday, 10/18/2016
CRISPR Therapeutics AG: Initial statement of beneficial ownership of securities
3
Tuesday, 5/5/2015
HTG MOLECULAR DIAGNOSTICS, INC: Initial statement of beneficial ownership of securities
4
Tuesday, 2/11/2014
GENOCEA BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
3
Tuesday, 2/4/2014
GENOCEA BIOSCIENCES, INC.: Initial statement of beneficial ownership of securities